Also in 2005 all long-term targets were met. Novozymes achieved solid earnings and continued growth in profit margins, as well as a high level of free cash flow. Earnings were significantly better than anticipated at the beginning of the year.
2005 was a year when innovation and the development in emerging markets were the primary growth drivers for Novozymes.
The combination of better economy and environmental benefits for customers is key to Novozymes' commercial success. Lifecycle assessments of a series of products provide better documentation of the environmental benefits of biological solutions.
